img

Global Whole Genome and Exome Sequencing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Whole Genome and Exome Sequencing Market Research Report 2024

Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
According to MRAResearch’s new survey, global Whole Genome and Exome Sequencing market is projected to reach US$ 623.8 million in 2033, increasing from US$ 296 million in 2022, with the CAGR of 11.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Whole Genome and Exome Sequencing market research.
Key companies engaged in the Whole Genome and Exome Sequencing industry include Eurofins Scientific SE, Agilent Technologies, Inc, Beijing Genomics Institute (BGI), Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, GENEWIZ, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Novogene Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Whole Genome and Exome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Whole Genome and Exome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Whole Genome and Exome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Segment by Type
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)

Segment by Application


Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Whole Genome and Exome Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Product
1.2.1 Global Whole Genome and Exome Sequencing Market Size Growth Rate By Product: 2018 VS 2022 VS 2033
1.2.2 Kits
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Whole Genome and Exome Sequencing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Diagnostic Labs
1.3.5 Research Centres, Academia and Government Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Genome and Exome Sequencing Market Perspective (2018-2033)
2.2 Whole Genome and Exome Sequencing Growth Trends by Region
2.2.1 Global Whole Genome and Exome Sequencing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Whole Genome and Exome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Whole Genome and Exome Sequencing Forecasted Market Size by Region (2024-2033)
2.3 Whole Genome and Exome Sequencing Market Dynamics
2.3.1 Whole Genome and Exome Sequencing Industry Trends
2.3.2 Whole Genome and Exome Sequencing Market Drivers
2.3.3 Whole Genome and Exome Sequencing Market Challenges
2.3.4 Whole Genome and Exome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Whole Genome and Exome Sequencing Players by Revenue
3.1.1 Global Top Whole Genome and Exome Sequencing Players by Revenue (2018-2023)
3.1.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Whole Genome and Exome Sequencing Revenue
3.4 Global Whole Genome and Exome Sequencing Market Concentration Ratio
3.4.1 Global Whole Genome and Exome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Genome and Exome Sequencing Revenue in 2022
3.5 Whole Genome and Exome Sequencing Key Players Head office and Area Served
3.6 Key Players Whole Genome and Exome Sequencing Product Solution and Service
3.7 Date of Enter into Whole Genome and Exome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Genome and Exome Sequencing Breakdown Data by Type
4.1 Global Whole Genome and Exome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2024-2033)
5 Whole Genome and Exome Sequencing Breakdown Data by Application
5.1 Global Whole Genome and Exome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Whole Genome and Exome Sequencing Market Size (2018-2033)
6.2 North America Whole Genome and Exome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Whole Genome and Exome Sequencing Market Size by Country (2018-2023)
6.4 North America Whole Genome and Exome Sequencing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Whole Genome and Exome Sequencing Market Size (2018-2033)
7.2 Europe Whole Genome and Exome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Whole Genome and Exome Sequencing Market Size by Country (2018-2023)
7.4 Europe Whole Genome and Exome Sequencing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size (2018-2033)
8.2 Asia-Pacific Whole Genome and Exome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Whole Genome and Exome Sequencing Market Size (2018-2033)
9.2 Latin America Whole Genome and Exome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Whole Genome and Exome Sequencing Market Size by Country (2018-2023)
9.4 Latin America Whole Genome and Exome Sequencing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Whole Genome and Exome Sequencing Market Size (2018-2033)
10.2 Middle East & Africa Whole Genome and Exome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific SE
11.1.1 Eurofins Scientific SE Company Detail
11.1.2 Eurofins Scientific SE Business Overview
11.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Introduction
11.1.4 Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.1.5 Eurofins Scientific SE Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Detail
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.2.4 Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Beijing Genomics Institute (BGI)
11.3.1 Beijing Genomics Institute (BGI) Company Detail
11.3.2 Beijing Genomics Institute (BGI) Business Overview
11.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Introduction
11.3.4 Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.3.5 Beijing Genomics Institute (BGI) Recent Development
11.4 Hoffmann-La Roche Ltd
11.4.1 Hoffmann-La Roche Ltd Company Detail
11.4.2 Hoffmann-La Roche Ltd Business Overview
11.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Introduction
11.4.4 Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.4.5 Hoffmann-La Roche Ltd Recent Development
11.5 Bio-Rad Laboratories, Inc
11.5.1 Bio-Rad Laboratories, Inc Company Detail
11.5.2 Bio-Rad Laboratories, Inc Business Overview
11.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Introduction
11.5.4 Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.5.5 Bio-Rad Laboratories, Inc Recent Development
11.6 GENEWIZ, Inc
11.6.1 GENEWIZ, Inc Company Detail
11.6.2 GENEWIZ, Inc Business Overview
11.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Introduction
11.6.4 GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.6.5 GENEWIZ, Inc Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Detail
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Whole Genome and Exome Sequencing Introduction
11.7.4 Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.7.5 Illumina, Inc Recent Development
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Detail
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Introduction
11.8.4 Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.8.5 Laboratory Corporation of America Holdings Recent Development
11.9 Novogene Corporation
11.9.1 Novogene Corporation Company Detail
11.9.2 Novogene Corporation Business Overview
11.9.3 Novogene Corporation Whole Genome and Exome Sequencing Introduction
11.9.4 Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.9.5 Novogene Corporation Recent Development
11.10 Oxford Nanopore Technologies, Inc
11.10.1 Oxford Nanopore Technologies, Inc Company Detail
11.10.2 Oxford Nanopore Technologies, Inc Business Overview
11.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Introduction
11.10.4 Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.10.5 Oxford Nanopore Technologies, Inc Recent Development
11.11 Pacific Biosciences of California, Inc
11.11.1 Pacific Biosciences of California, Inc Company Detail
11.11.2 Pacific Biosciences of California, Inc Business Overview
11.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.11.5 Pacific Biosciences of California, Inc Recent Development
11.12 QIAGEN N.V
11.12.1 QIAGEN N.V Company Detail
11.12.2 QIAGEN N.V Business Overview
11.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Introduction
11.12.4 QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.12.5 QIAGEN N.V Recent Development
11.13 Thermo Fisher Scientific Inc
11.13.1 Thermo Fisher Scientific Inc Company Detail
11.13.2 Thermo Fisher Scientific Inc Business Overview
11.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Introduction
11.13.4 Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.13.5 Thermo Fisher Scientific Inc Recent Development
11.14 Cytiva
11.14.1 Cytiva Company Detail
11.14.2 Cytiva Business Overview
11.14.3 Cytiva Whole Genome and Exome Sequencing Introduction
11.14.4 Cytiva Revenue in Whole Genome and Exome Sequencing Business (2018-2023)
11.14.5 Cytiva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Whole Genome and Exome Sequencing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Kits
Table 3. Key Players of Instruments
Table 4. Global Whole Genome and Exome Sequencing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Whole Genome and Exome Sequencing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Whole Genome and Exome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Whole Genome and Exome Sequencing Market Share by Region (2018-2023)
Table 8. Global Whole Genome and Exome Sequencing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Whole Genome and Exome Sequencing Market Share by Region (2024-2033)
Table 10. Whole Genome and Exome Sequencing Market Trends
Table 11. Whole Genome and Exome Sequencing Market Drivers
Table 12. Whole Genome and Exome Sequencing Market Challenges
Table 13. Whole Genome and Exome Sequencing Market Restraints
Table 14. Global Whole Genome and Exome Sequencing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Whole Genome and Exome Sequencing Market Share by Players (2018-2023)
Table 16. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome and Exome Sequencing as of 2022)
Table 17. Ranking of Global Top Whole Genome and Exome Sequencing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Whole Genome and Exome Sequencing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Whole Genome and Exome Sequencing Product Solution and Service
Table 21. Date of Enter into Whole Genome and Exome Sequencing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Whole Genome and Exome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2018-2023)
Table 25. Global Whole Genome and Exome Sequencing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Whole Genome and Exome Sequencing Revenue Market Share by Type (2024-2033)
Table 27. Global Whole Genome and Exome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2018-2023)
Table 29. Global Whole Genome and Exome Sequencing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Whole Genome and Exome Sequencing Revenue Market Share by Application (2024-2033)
Table 31. North America Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Whole Genome and Exome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Whole Genome and Exome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Whole Genome and Exome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Whole Genome and Exome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Whole Genome and Exome Sequencing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Whole Genome and Exome Sequencing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Whole Genome and Exome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Whole Genome and Exome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Whole Genome and Exome Sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Whole Genome and Exome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Eurofins Scientific SE Company Detail
Table 47. Eurofins Scientific SE Business Overview
Table 48. Eurofins Scientific SE Whole Genome and Exome Sequencing Product
Table 49. Eurofins Scientific SE Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 50. Eurofins Scientific SE Recent Development
Table 51. Agilent Technologies, Inc Company Detail
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Whole Genome and Exome Sequencing Product
Table 54. Agilent Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 55. Agilent Technologies, Inc Recent Development
Table 56. Beijing Genomics Institute (BGI) Company Detail
Table 57. Beijing Genomics Institute (BGI) Business Overview
Table 58. Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product
Table 59. Beijing Genomics Institute (BGI) Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 60. Beijing Genomics Institute (BGI) Recent Development
Table 61. Hoffmann-La Roche Ltd Company Detail
Table 62. Hoffmann-La Roche Ltd Business Overview
Table 63. Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product
Table 64. Hoffmann-La Roche Ltd Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 65. Hoffmann-La Roche Ltd Recent Development
Table 66. Bio-Rad Laboratories, Inc Company Detail
Table 67. Bio-Rad Laboratories, Inc Business Overview
Table 68. Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product
Table 69. Bio-Rad Laboratories, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 70. Bio-Rad Laboratories, Inc Recent Development
Table 71. GENEWIZ, Inc Company Detail
Table 72. GENEWIZ, Inc Business Overview
Table 73. GENEWIZ, Inc Whole Genome and Exome Sequencing Product
Table 74. GENEWIZ, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 75. GENEWIZ, Inc Recent Development
Table 76. Illumina, Inc Company Detail
Table 77. Illumina, Inc Business Overview
Table 78. Illumina, Inc Whole Genome and Exome Sequencing Product
Table 79. Illumina, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 80. Illumina, Inc Recent Development
Table 81. Laboratory Corporation of America Holdings Company Detail
Table 82. Laboratory Corporation of America Holdings Business Overview
Table 83. Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product
Table 84. Laboratory Corporation of America Holdings Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 85. Laboratory Corporation of America Holdings Recent Development
Table 86. Novogene Corporation Company Detail
Table 87. Novogene Corporation Business Overview
Table 88. Novogene Corporation Whole Genome and Exome Sequencing Product
Table 89. Novogene Corporation Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 90. Novogene Corporation Recent Development
Table 91. Oxford Nanopore Technologies, Inc Company Detail
Table 92. Oxford Nanopore Technologies, Inc Business Overview
Table 93. Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product
Table 94. Oxford Nanopore Technologies, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 95. Oxford Nanopore Technologies, Inc Recent Development
Table 96. Pacific Biosciences of California, Inc Company Detail
Table 97. Pacific Biosciences of California, Inc Business Overview
Table 98. Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product
Table 99. Pacific Biosciences of California, Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 100. Pacific Biosciences of California, Inc Recent Development
Table 101. QIAGEN N.V Company Detail
Table 102. QIAGEN N.V Business Overview
Table 103. QIAGEN N.V Whole Genome and Exome Sequencing Product
Table 104. QIAGEN N.V Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 105. QIAGEN N.V Recent Development
Table 106. Thermo Fisher Scientific Inc Company Detail
Table 107. Thermo Fisher Scientific Inc Business Overview
Table 108. Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product
Table 109. Thermo Fisher Scientific Inc Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 110. Thermo Fisher Scientific Inc Recent Development
Table 111. Cytiva Company Detail
Table 112. Cytiva Business Overview
Table 113. Cytiva Whole Genome and Exome Sequencing Product
Table 114. Cytiva Revenue in Whole Genome and Exome Sequencing Business (2018-2023) & (US$ Million)
Table 115. Cytiva Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Whole Genome and Exome Sequencing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Whole Genome and Exome Sequencing Market Share by Type: 2022 VS 2033
Figure 3. Kits Features
Figure 4. Instruments Features
Figure 5. Global Whole Genome and Exome Sequencing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Whole Genome and Exome Sequencing Market Share by Application: 2022 VS 2033
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Diagnostic Labs Case Studies
Figure 10. Research Centres, Academia and Government Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Whole Genome and Exome Sequencing Report Years Considered
Figure 13. Global Whole Genome and Exome Sequencing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Whole Genome and Exome Sequencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Whole Genome and Exome Sequencing Market Share by Region: 2022 VS 2033
Figure 16. Global Whole Genome and Exome Sequencing Market Share by Players in 2022
Figure 17. Global Top Whole Genome and Exome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Genome and Exome Sequencing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Whole Genome and Exome Sequencing Revenue in 2022
Figure 19. North America Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Whole Genome and Exome Sequencing Market Share by Country (2018-2033)
Figure 21. United States Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Whole Genome and Exome Sequencing Market Share by Country (2018-2033)
Figure 25. Germany Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Whole Genome and Exome Sequencing Market Share by Region (2018-2033)
Figure 33. China Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Whole Genome and Exome Sequencing Market Share by Country (2018-2033)
Figure 41. Mexico Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Whole Genome and Exome Sequencing Market Share by Country (2018-2033)
Figure 45. Turkey Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Whole Genome and Exome Sequencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Eurofins Scientific SE Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 48. Agilent Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 49. Beijing Genomics Institute (BGI) Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 50. Hoffmann-La Roche Ltd Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 51. Bio-Rad Laboratories, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 52. GENEWIZ, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 53. Illumina, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 54. Laboratory Corporation of America Holdings Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 55. Novogene Corporation Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 56. Oxford Nanopore Technologies, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 57. Pacific Biosciences of California, Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 58. QIAGEN N.V Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 59. Thermo Fisher Scientific Inc Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 60. Cytiva Revenue Growth Rate in Whole Genome and Exome Sequencing Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed